Apg Asset Management Us Inc. Neurocrine Biosciences Inc Transaction History
Apg Asset Management Us Inc.
- $14.6 Billion
- Q3 2024
A detailed history of Apg Asset Management Us Inc. transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Apg Asset Management Us Inc. holds 2,311 shares of NBIX stock, worth $315,451. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,311
Previous 27,953
91.73%
Holding current value
$315,451
Previous $3.85 Million
93.09%
% of portfolio
0.0%
Previous 0.02%
Shares
4 transactions
Others Institutions Holding NBIX
# of Institutions
626Shares Held
94MCall Options Held
632KPut Options Held
621K-
Black Rock Inc. New York, NY14.2MShares$1.94 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA10MShares$1.36 Billion0.02% of portfolio
-
State Street Corp Boston, MA5.15MShares$703 Million0.02% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2.57MShares$351 Million0.47% of portfolio
-
Bellevue Group Ag Kuesnacht, V81.86MShares$254 Million3.62% of portfolio
About NEUROCRINE BIOSCIENCES INC
- Ticker NBIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 95,639,296
- Market Cap $13.1B
- Description
- Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...